↓ Skip to main content

Recombinant Virus Vaccines

Overview of attention for book
Attention for Chapter 12: Generating Recombinant Vesicular Stomatitis Viruses for Use as Vaccine Platforms
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Generating Recombinant Vesicular Stomatitis Viruses for Use as Vaccine Platforms
Chapter number 12
Book title
Recombinant Virus Vaccines
Published in
Methods in molecular biology, April 2017
DOI 10.1007/978-1-4939-6869-5_12
Pubmed ID
Book ISBNs
978-1-4939-6867-1, 978-1-4939-6869-5
Authors

John B. Ruedas, John H. Connor

Editors

Maureen C. Ferran, Gary R. Skuse

Abstract

The unique properties of vesicular stomatitis virus (VSV) make it a promising vaccine platform. With the advent of plasmid-based approaches to generate recombinant VSV viruses that express glycoproteins of other viruses, researchers now have the means to generate vaccine candidates targeting a variety of human pathogens. This chapter gives a general overview of the workings of VSV as a vaccine platform and provides a detailed protocol for the generation of recombinant VSV from plasmids.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 38%
Professor > Associate Professor 1 8%
Student > Ph. D. Student 1 8%
Unknown 6 46%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 31%
Biochemistry, Genetics and Molecular Biology 2 15%
Immunology and Microbiology 1 8%
Unknown 6 46%